1. Home
  2. BANL vs CVKD Comparison

BANL vs CVKD Comparison

Compare BANL & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BANL
  • CVKD
  • Stock Information
  • Founded
  • BANL 2015
  • CVKD 2022
  • Country
  • BANL Malaysia
  • CVKD United States
  • Employees
  • BANL N/A
  • CVKD N/A
  • Industry
  • BANL Oil Refining/Marketing
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • BANL Energy
  • CVKD Health Care
  • Exchange
  • BANL Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • BANL 25.3M
  • CVKD 29.5M
  • IPO Year
  • BANL 2023
  • CVKD 2023
  • Fundamental
  • Price
  • BANL $0.76
  • CVKD $12.68
  • Analyst Decision
  • BANL
  • CVKD Strong Buy
  • Analyst Count
  • BANL 0
  • CVKD 1
  • Target Price
  • BANL N/A
  • CVKD $32.00
  • AVG Volume (30 Days)
  • BANL 693.8K
  • CVKD 33.5K
  • Earning Date
  • BANL 04-16-2025
  • CVKD 08-06-2025
  • Dividend Yield
  • BANL N/A
  • CVKD N/A
  • EPS Growth
  • BANL N/A
  • CVKD N/A
  • EPS
  • BANL N/A
  • CVKD N/A
  • Revenue
  • BANL $592,517,545.00
  • CVKD N/A
  • Revenue This Year
  • BANL N/A
  • CVKD N/A
  • Revenue Next Year
  • BANL N/A
  • CVKD N/A
  • P/E Ratio
  • BANL N/A
  • CVKD N/A
  • Revenue Growth
  • BANL 35.93
  • CVKD N/A
  • 52 Week Low
  • BANL $0.55
  • CVKD $5.70
  • 52 Week High
  • BANL $1.35
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • BANL 42.74
  • CVKD 47.47
  • Support Level
  • BANL $0.72
  • CVKD $11.00
  • Resistance Level
  • BANL $1.03
  • CVKD $13.24
  • Average True Range (ATR)
  • BANL 0.10
  • CVKD 1.13
  • MACD
  • BANL -0.01
  • CVKD 0.20
  • Stochastic Oscillator
  • BANL 14.51
  • CVKD 72.33

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: